According to a report, a survey of 346 doctors revealed that 89% of them have seen a recent increase in patients requesting weight-loss medications in 2023.

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...

(Reuters) -OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other ...

Sirona is a dual-polymer hydrogel pill that expands in the stomach, reducing appetite. Participants consumed 400 fewer ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

Emmerdale star Lisa Riley has said it's "devastating" that people are being conned out of money by scammers using her image ...